NCT00024076View on ClinicalTrials.gov

Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2000

Primary Completion Date

December 31, 2006

Conditions
Lung CancerMalignant MesotheliomaMetastatic CancerThymoma and Thymic Carcinoma
Interventions
PROCEDURE

radiofrequency ablation

Trial Locations (1)

90095-1781

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

All Listed Sponsors
lead

Jonsson Comprehensive Cancer Center

OTHER

NCT00024076 - Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer | Biotech Hunter | Biotech Hunter